GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,508,000 | +21.6% | 103,298 | +18.3% | 0.00% | 0.0% |
| Q3 2020 | $1,240,000 | -20.5% | 87,298 | -17.6% | 0.00% | 0.0% |
| Q2 2020 | $1,559,000 | +256.8% | 105,998 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $437,000 | -14.3% | 105,998 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $510,000 | -39.8% | 105,998 | -24.2% | 0.00% | 0.0% |
| Q3 2019 | $847,000 | -14.3% | 139,798 | -8.2% | 0.00% | 0.0% |
| Q2 2019 | $988,000 | -8.5% | 152,216 | -0.1% | 0.00% | -50.0% |
| Q1 2019 | $1,080,000 | +40.8% | 152,316 | -3.5% | 0.00% | +100.0% |
| Q4 2018 | $767,000 | -45.0% | 157,816 | -16.8% | 0.00% | -50.0% |
| Q3 2018 | $1,394,000 | +20.7% | 189,616 | +4.8% | 0.00% | 0.0% |
| Q2 2018 | $1,155,000 | +18.8% | 181,016 | +1.3% | 0.00% | +100.0% |
| Q1 2018 | $972,000 | +33.5% | 178,616 | +2.3% | 0.00% | 0.0% |
| Q4 2017 | $728,000 | -42.0% | 174,516 | +34.0% | 0.00% | -50.0% |
| Q3 2017 | $1,255,000 | -7.3% | 130,280 | +13.8% | 0.00% | 0.0% |
| Q2 2017 | $1,354,000 | +3.4% | 114,468 | +12.1% | 0.00% | 0.0% |
| Q1 2017 | $1,309,000 | +8.0% | 102,074 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $1,212,000 | +3.8% | 99,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,168,000 | +167.3% | 99,000 | +97.2% | 0.00% | +100.0% |
| Q2 2016 | $437,000 | +62.5% | 50,200 | -1.6% | 0.00% | 0.0% |
| Q1 2016 | $269,000 | -32.2% | 51,000 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $397,000 | -5.9% | 51,100 | -4.7% | 0.00% | 0.0% |
| Q3 2015 | $422,000 | -10.2% | 53,600 | +3.3% | 0.00% | 0.0% |
| Q2 2015 | $470,000 | -29.6% | 51,900 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $668,000 | -4.7% | 51,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $701,000 | +51.7% | 51,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $462,000 | -33.7% | 51,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $697,000 | +36.1% | 51,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $512,000 | -20.0% | 51,500 | +7.1% | 0.00% | 0.0% |
| Q4 2013 | $640,000 | -28.7% | 48,100 | -34.9% | 0.00% | -50.0% |
| Q3 2013 | $898,000 | +43.5% | 73,900 | +22.1% | 0.00% | +100.0% |
| Q2 2013 | $626,000 | – | 60,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |